Showing results (341-350 of 423) with videos related to

Sort By:
Pageof 43
Herzschrittmachertherapie & Elektrophysiologie|May 19, 2021
[Puncture techniques in invasive cardiac electrophysiology]David Duncker, Philipp Sommer, Sonia Busch, et al.
Nature Communications|August 12, 2025
Estimated transmission dynamics of SARS-CoV-2 variants from wastewater are unbiased and robust to differential sheddingDavid Dreifuss, Jana S Huisman, Johannes C Rusch, et al.
Science (New York, N.Y.)|October 13, 2001
Magnetic field-tuned quantum criticality in the metallic ruthenate Sr3Ru2O7S A Grigera, R S Perry, A J Schofield, et al.
European Heart Journal|July 13, 2019
Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized dataShaojie Chen, Helmut Pürerfellner, Christian Meyer, et al.
Herzschrittmachertherapie & Elektrophysiologie|January 30, 2024
[Perioperative management for cardiovascular implantable electronic devices]Konstantin Krieger, Innu Park, Till Althoff, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 4, 2022
Impact of first-line cryoablation for atrial fibrillation on healthcare utilization, arrhythmia disease burden and efficacy outcomes: real-world evidence from the Cryo Global RegistryGiulio Zucchelli, K R Julian Chun, Surinder Kaur Khelae, et al.
Physical Review Letters|February 28, 2002
Sensitivity to disorder of the metallic state in the ruthenatesL Capogna, A P Mackenzie, R S Perry, et al.
The New England Journal of Medicine|April 5, 2016
Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial FibrillationKarl-Heinz Kuck, Josep Brugada, Alexander Fürnkranz, et al.
Angewandte Chemie (International Ed. in English)|March 20, 2023
Decoding the Fucose Migration Product during Mass-Spectrometric analysis of Blood Group EpitopesMaike Lettow, Kim Greis, Eike Mucha, et al.
Urology|November 16, 2005
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastasesThomas J Polascik, Robert W Given, Charles Metzger, et al.
Pageof 43